Vanguard Capital Management’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.9M Buy
160,648
+42,948
+36% +$557K ﹤0.01% 3385
2026
Q2
$1.55M Buy
117,700
+268
+0.2% +$5.98K ﹤0.01% 3494
2026
Q1
$3.09M Buy
+117,432
New +$14.8M ﹤0.01% 3225

Other funds holding GOSS

Vanguard Capital Management's GOSS Position: Q3 2026 in Review

Vanguard Capital Management increased its Gossamer Bio (GOSS) stake by 36% in Q3 2026, buying an estimated $557K and bringing the position to 160,648 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3385.

Vanguard Capital Management first reported a position in GOSS in Q1 2026 and has held it in 3 quarters since. The position peaked at $3.09M in Q1 2026. 76 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

  • Vanguard Capital Management held 160,648 shares of Gossamer Bio worth $1.9M as of Q3 2026.
  • Vanguard Capital Management bought 42,948 Gossamer Bio shares in Q3 2026, an estimated $557K.
  • Gossamer Bio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3385 holding.
  • Vanguard Capital Management first reported a position in Gossamer Bio in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Gossamer Bio position peaked at $3.09M in Q1 2026.
  • 76 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.